Investigation of the Antiangiogenic Properties of Zoledronic Acid by Using Chorioallantoic Membrane Model

OBJECTIVE: Zoledronic acid (ZA) is a bisphosphonate-derived agent used in osteoporotic clinical pathologies to prevent the development of complications such as fractures and hypercalcemia by regulating bone metabolism. Studies have been conducted on the antiangiogenic efficacy of this agent, which a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulcu, Anil, Akkaya, Ozgur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087255/
https://www.ncbi.nlm.nih.gov/pubmed/35558869
http://dx.doi.org/10.1177/15593258221093410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087255/
https://www.ncbi.nlm.nih.gov/pubmed/35558869
http://dx.doi.org/10.1177/15593258221093410

Ejemplares similares